In vitro evaluation of antibiotic release from and bacteria growth inhibition by antibiotic-loaded acrylic bone cement spacers

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 72, Issue 2, 2005, Pages 373-378

  Anagnostakos, Konstantinos ^a   Kelm, Jens ^a,d   Regitz, Thilo ^b   Schmitt, Eduard ^a   Jung, Werner ^c  

^a Orthopadische Univ Klin H   (Germany)

^b Firma Regitz   (Germany)

^c Abteilung Bakteriologie und Hygiene   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

Antimicrobial; Bone cement (PMMA, acrylic); Drug delivery; Drug release

Indexed keywords

ANTIBIOTICS; BIOASSAY; BONE CEMENT; ENZYME INHIBITION; FLUORESCENCE; IMMUNOLOGY;

ANIBIOTIC POWDER; BACTERIA GROWTH; BONE CEMENT HIP SPACERS;

BACTERIA;

ACRYLIC CEMENT; AMINOGLYCOSIDE; GENTAMICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INHIBITION; DRUG RELEASE; ELUTION; ENTEROCOCCUS FAECALIS; FLUORESCENCE POLARIZATION IMMUNOASSAY; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PHOTOMETRY; POWDER; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TOTAL HIP PROSTHESIS;

ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BACTERIA; DRUG COMBINATIONS; DRUG DELIVERY SYSTEMS; DRUG SYNERGISM; ENTEROCOCCUS FAECALIS; FLUORESCENCE POLARIZATION IMMUNOASSAY; HIP JOINT; HUMANS; INFECTION; MATERIALS TESTING; MODELS, BIOLOGICAL; POLYMETHYL METHACRYLATE; STAPHYLOCOCCUS;

EID: 12744253427     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.30171     Document Type: Article

References (23)

1. Buchholz HW, Engelbrecht E. Über die Depotwirkung einiger Antibiotika bei Vermischung mit dem Kunstharz Palacos. Chirurg 1970;41:511-515.
2. Hanssen AD, Rand AJ. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. J Bone Joint Surg 1998;80:910-922.
3. Isiklar ZU, Demirörs H, Akpinar S, Tandogan RN, Alparslan M. Two-stage treatment of chronic staphylococcal implantrelated infections using vancomycin-impregnated PMMA-spacer and rifampicin containing antibiotic protocol. Bull Hosp Jt Dis 1999;58:79-85.
4. Steinbrink K, Frommelt L. Treatment of periprosthetic infection of the hip using one-stage exchange surgery. Orthopäde 1995;24:335-343.
5. Deshmukh RG, Thevarajan K, Kok CS, Sivapathasundaram N, George SV. An intramedullary cement spacer in total hip arthroplasty. J Arthroplasty 1998;13:197-199.
6. Koo K-H, Yang J-W, Cho S-H, Song H-R, Park H-B, Ha Y-C, Chang J-D, Kim S-Y, Kim Y-H. Impregnation of vancomycin, gentamicin and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty. J Arthroplasty 2001;16:882-892.
7. Esenwein SA, Robert K, Kollig E, Ambacher T, Kutscha-Lissberg F, Muhr G. Long-term results after resection arthroplasty according to Girdlestone for treatment of persisting infections of the hip joint. Chirurg 2001;72:1336-1343.
8. Magnan B, Regis D, Biscaglia R, Bartolozzi P. Preformed acrylic bone cement spacer loaded with antibiotics. Use of two-stage procedure in 10 patients because of infected hips after total replacement. Acta Orthop Scand 2001;72:591-594.
9. Murray WR. Use of antibiotic-containing bone cement. Clin Orthop 1984;190:89-95.
10. Wahlig H. Über die Freisetzungskinetik von Antibiotika aus Knochenzementen - Ergebnisse vergleichender Untersuchungen in vitro und in vivo. Aktuelle Probl Chir Orthop 1987;31:221-226.
11. Masri BA, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bone-cement. J Arthroplasty 1998;13:331-338.
12. Younger ASE, Duncan CP, Masri BA, McGraw RW. The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hip. J Arthroplasty 1997;12:615-623.
13. Masri BA, Duncan CP, Beauchamp CP, Paris NJ, Arntorp J. Tobramycin and vancomycin elution from bone cement. An in vivo and in vitro study. Orthop Trans 1994;18:130.
14. Holtom PD. Relation of surface area to in vitro elution characteristics of vancomycin-impregnated polymethylmethylacrylate spacers. Am J Orthop 1998;27:207-210.
15. Barr JG, Smyth ETM, Hogg GM. In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis 1990;9:804-809.
16. Pallanza R, Scotti R, Arioli V. Bactericidal activity of teicoplanin in an in-vitro two-compartment kinetic model. J Antimicrob Chemother 1988;21:15-21.
17. Wallrauch C, Eisner E, Milatovic D, Cremer J, Braveny I. Antibiotikaresistenz der Enterokokken in Deutschland. Med Klin 1997;92:464-468.
18. Wendt C, Rüden H, Edmond M. Vancomycin-resistente Enterokokken. Deutsches Ärzteblatt 1998;95:1284-1291.
19. Duncan CP, Beauchamp C. A temporary antibiotic-loaded joint replacement system for management of complex infections involving the hip. Orthop Clin North Am 1993;24:751-759.
20. Penner MJ, Masri BA, Duncan CP. Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty 1996;11:939-944.
21. Garvin K, Hinrichs S, Urban J. Emerging antibiotic-resistant bacteria. Clin Orthop 1999;369:110-123.
22. Pfeil E, Wiedermann B. Pharmakodynamik von Quinopristin-Dalfopristin gegenüber MSSA und drei klonal in Deutschland verbreiteten MRSA-Stämmen im Vergleich zu anderen Antibiotika. Chemother J 2000;19:33-37.
23. Von Eiff C. In-vitro-Aktivität von Quinopristin-Dalfopristin gegenüber Staphylokokken und anderen grampositiven Erregern. Chemother J 2000;19:24-26.